Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10508858rdf:typepubmed:Citationlld:pubmed
pubmed-article:10508858lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0007097lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0071216lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0678686lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C2611831lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10508858lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:10508858pubmed:issue1lld:pubmed
pubmed-article:10508858pubmed:dateCreated1999-11-4lld:pubmed
pubmed-article:10508858pubmed:abstractTextMechanisms that regulate the transition of metastases from clinically undetectable and dormant to progressively growing are the least understood aspects of cancer biology. Here, we show that a large ( approximately 70%) reduction in the urokinase plasminogen activator receptor (uPAR) level in human carcinoma HEp3 cells, while not affecting their in vitro growth, induced a protracted state of tumor dormancy in vivo, with G(0)/G(1) arrest. We have now identified the mechanism responsible for the induction of dormancy. We found that uPA/uPAR proteins were physically associated with alpha5beta1, and that in cells with low uPAR the frequency of this association was significantly reduced, leading to a reduced avidity of alpha5beta1 and a lower adhesion of cells to the fibronectin (FN). Adhesion to FN resulted in a robust and persistent ERK1/2 activation and serum-independent growth stimulation of only uPAR-rich cells. Compared with uPAR-rich tumorigenic cells, the basal level of active extracellular regulated kinase (ERK) was four to sixfold reduced in uPAR-poor dormant cells and its stimulation by single chain uPA (scuPA) was weak and showed slow kinetics. The high basal level of active ERK in uPAR-rich cells could be strongly and rapidly stimulated by scuPA. Disruption of uPAR-alpha5beta1 complexes in uPAR-rich cells with antibodies or a peptide that disrupts uPAR-beta1 interactions, reduced the FN-dependent ERK1/2 activation. These results indicate that dormancy of low uPAR cells may be the consequence of insufficient uPA/uPAR/alpha5beta1 complexes, which cannot induce ERK1/2 activity above a threshold needed to sustain tumor growth in vivo. In support of this conclusion we found that treatment of uPAR-rich cells, which maintain high ERK activity in vivo, with reagents interfering with the uPAR/beta1 signal to ERK activation, mimic the in vivo dormancy induced by downregulation of uPAR.lld:pubmed
pubmed-article:10508858pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:languageenglld:pubmed
pubmed-article:10508858pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:citationSubsetIMlld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10508858pubmed:statusMEDLINElld:pubmed
pubmed-article:10508858pubmed:monthOctlld:pubmed
pubmed-article:10508858pubmed:issn0021-9525lld:pubmed
pubmed-article:10508858pubmed:authorpubmed-author:OssowskiLLlld:pubmed
pubmed-article:10508858pubmed:authorpubmed-author:Aguirre...lld:pubmed
pubmed-article:10508858pubmed:authorpubmed-author:KovalskiKKlld:pubmed
pubmed-article:10508858pubmed:issnTypePrintlld:pubmed
pubmed-article:10508858pubmed:day4lld:pubmed
pubmed-article:10508858pubmed:volume147lld:pubmed
pubmed-article:10508858pubmed:ownerNLMlld:pubmed
pubmed-article:10508858pubmed:authorsCompleteYlld:pubmed
pubmed-article:10508858pubmed:pagination89-104lld:pubmed
pubmed-article:10508858pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
pubmed-article:10508858pubmed:meshHeadingpubmed-meshheading:10508858...lld:pubmed
More...